Is prophylactic β-adrenergic blockade appropriate in mitral regurgitation: Impact of cellular pathophysiology

Advances in Cardiology

Volumn 41, Issue , 2005, Pages 25-35

  Starling, Mark R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL; CHRONIC DISEASE; DRUG EFFECT; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CHRONIC DISEASE; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL CONTRACTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4344630299     PISSN: 00652326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Enriquez-Sarano M, Tajik AJ, Schaff HV et al: Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-837.
2. Enriquez-Sarano M, Schaff HV Orszulak TA, Bailey KR, Tajik AJ, Frye RL: Congestive heart failure after surgical correction of mitral regurgitation: A long-term study. Circulation 1995;92:2496-2503.
3. Wisenbaugh T, Spann JF, Carabello BA: Differences in myocardial performance and load between patients with similar amount of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1984;3:916-923.
4. Starling MR, Kirsh MM, Montgomery DG, Gross MD: Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 1993;22:239-250.
5. Starling MR: Effects of valve surgery on left ventricular contractile function in patients with longterm mitral regurgitation. Circulation 1995;92:811-818.
6. Nakano K, Swindle MM, Spinale F, et al: Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J Clin Invest 1991;87:2077-2086.
7. Linares OA, Jacquez JA, Zech LA, et al: Norepinephrine metabolism in humans: Kinetic analysis and model. J Clin Invest 1987;80:1332-1341.
8. Mehta R, Supiano MA, Oral H, Grossman PA, Starling MR: Compared to control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. Am Heart J 2003;145:1078-1085.
9. Rosen SG, Supiano MA, Perry TJ, Linares OA, Hogikyan RV Smith MJ, Halther JB: Beta-adrenergic blockade decreases norepinephrine release in humans. Am J Physiol 1990;258:E999-E1005.
10. Ross J, Miura T, Kambayashi M, Eising GP, Ryu KH: Adrenergic control of the force-frequency relation. Circulation 1995;92:2327-2332.
11. Mulieri LA, Leavitt BJ, Martin BJ, Haeberle JR, Alpert NR: Myocardial force-frequency defect in mitral regurgitation is reversed by forskolin. Circulation 1993;88:2700-2704.
12. Tsutsui H, Spinale FG, Nagatsu M, et al: Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 1994; 93:2639-2648.
13. Shintaro N, Hamawaki M, De Freitas G, Carabello BA: Differential effects of the angiotensinconverting enzyme inhibitor lisinopril vs. the β-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002;40:149-154.
14. Mann DL, Kent RL, Parsons B, Cooper G: Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.